The Planning and Evaluation functions of the University of Colorado Cancer Center (UCCC) are conducted by groups of external and internal advisors who provide critical input and advice, both formal and informal, in the development of the programs and capabilities of the Cancer Center. The advice provided by these groups, along with the individual insight and information provided by UCCC leadership and other individuals and organizations, provides the substance from which the UCCC Strategic Plan is developed, implemented, evaluated, and revised. External advisory groups include the External Advisory Board (EAB), whose members include nationally recognized scientific experts in areas of cancer research of particular relevance to the research programs and shared resources of the UCCC as well as five Directors of NCI designated Cancer Centers. The Community Advisory Board (CAB) comprises business, community, and philanthropic leaders within the Denver region who are committed to the advancement of the center and play a major fundraising role. Other external advisory groups include specific EAB's for our Lung SPORE and developing large applications and individual consultants to provide advice and guidance on specific, strategic initiatives of the UCCC. Internal advisory groups engaged in planning and evaluation include the Internal Advisory Board (lAB), comprising both clinical and basic science department chairs or their representatives who meet quarterly with UCCC leadership. The Consortium Advisory Committee includes representatives from every UCCC consortium institution and assists in the development, implementation and evaluation of research initiatives of value to the UCCC consortium. Playing a principal role in internal planning and evaluation functions is the biweekly Executive Committee, consisting of the Director, Deputy Director, Senior Associate Director (AD) for Translational and Collaborative Research, and the AD's for Cancer Prevention and Control Clinical Services and Administration and Finance. Complementing the Executive Committee is the Governance Committee, convening monthly and comprising the Director, Deputy Director, all Associate Directors, Program Leaders and Shared Resource Directors. A number of Operational Committees provide input and evaluation to UCCC leadership on areas such as membership, protocol review and monitoring, clinical services, shared resource management, education, and seed grants. Other critical sources for planning and evaluation input are our center-wide and program retreats, seminar series, and symposia.

Public Health Relevance

NCl-designated Cancer Centers are the centerpiece of the national effort to reduce morbidity and mortality from cancer. As an NCl-designated Comprehensive Cancer Center, the University of Colorado Cancer Center (UCCC) is dedicated to the mission of developing more effective approaches to prevention, diagnosis, and therapy. Planning and Evaluation efforts of the UCCC provide the means through which strategic decision-making and subsequent implementation are conducted to accomplish the UCCC mission.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
5P30CA046934-26
Application #
8616645
Study Section
Subcommittee G - Education (NCI)
Project Start
Project End
Budget Start
2014-02-01
Budget End
2015-01-31
Support Year
26
Fiscal Year
2014
Total Cost
$4,803
Indirect Cost
$3,403
Name
University of Colorado Denver
Department
Type
DUNS #
041096314
City
Aurora
State
CO
Country
United States
Zip Code
80045
Merrick, Daniel T; Edwards, Michael G; Franklin, Wilbur A et al. (2018) Altered Cell-Cycle Control, Inflammation, and Adhesion in High-Risk Persistent Bronchial Dysplasia. Cancer Res 78:4971-4983
Hintzsche, Jennifer D; Yoo, Minjae; Kim, Jihye et al. (2018) IMPACT web portal: oncology database integrating molecular profiles with actionable therapeutics. BMC Med Genomics 11:26
Cao, Shengya; Zhou, Keda; Zhang, Zhening et al. (2018) Constitutive centromere-associated network contacts confer differential stability on CENP-A nucleosomes in vitro and in the cell. Mol Biol Cell 29:751-762
Petersen, Dennis R; Saba, Laura M; Sayin, Volkan I et al. (2018) Elevated Nrf-2 responses are insufficient to mitigate protein carbonylation in hepatospecific PTEN deletion mice. PLoS One 13:e0198139
Li, Howard Y; McSharry, Maria; Walker, Deandra et al. (2018) Targeted overexpression of prostacyclin synthase inhibits lung tumor progression by recruiting CD4+ T lymphocytes in tumors that express MHC class II. Oncoimmunology 7:e1423182
Goldstein, Nathaniel B; Koster, Maranke I; Jones, Kenneth L et al. (2018) Repigmentation of Human Vitiligo Skin by NBUVB Is Controlled by Transcription of GLI1 and Activation of the ?-Catenin Pathway in the Hair Follicle Bulge Stem Cells. J Invest Dermatol 138:657-668
Korch, Christopher; Hall, Erin M; Dirks, Wilhelm G et al. (2018) Authentication of M14 melanoma cell line proves misidentification of MDA-MB-435 breast cancer cell line. Int J Cancer 142:561-572
Marwan, Ahmed I; Shabeka, Uladzimir; Reisz, Julie A et al. (2018) Unique Heterogeneous Topological Pattern of the Metabolic Landscape in Rabbit Fetal Lungs following Tracheal Occlusion. Fetal Diagn Ther :
Zhang, Lingdi; Zhou, Hengbo; Li, Xueni et al. (2018) Eya3 partners with PP2A to induce c-Myc stabilization and tumor progression. Nat Commun 9:1047
Dodson, R Blair; Powers, Kyle N; Gien, Jason et al. (2018) Intrauterine growth restriction decreases NF-?B signaling in fetal pulmonary artery endothelial cells of fetal sheep. Am J Physiol Lung Cell Mol Physiol 315:L348-L359

Showing the most recent 10 out of 1634 publications